Effects of the Bisphosphonate Olpadronate in Patients With Carcinoma of the Prostate Metastatic to the Skeleton
Authors:
- S.E PapapoulosSPS.E Papapoulos
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone MetastasesNew England Journal of Medicine, 1996
- Pyridinium cross‐links as urinary markers of bone metastases in patients with prostate cancerBritish Journal of Urology, 1996
- Pain relief and quality‐of‐life assessment following intravenous and oral clodronate in hormone‐escaped metastatic prostate cancerBritish Journal of Urology, 1995
- Effect of oral clodronate on bone painInternational Urology and Nephrology, 1992
- BisphosphonatesDrugs, 1991
- Clodronate Therapy of Metastatic Bone Disease in Patients with Prostatic Carcinoma1989
- Treatment of painful prostatic bone metastases with oral etidronate disodiumUrology, 1988
- Dichloromethylene-Diphosphonate in Patients with Prostatic Carcinoma Metastatic to the SkeletonJournal of Urology, 1985
- Spread of prostatic cancer to boneUrology, 1983
- Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma with special reference to osteomalaciaCancer, 1983